A detailed history of Morgan Stanley transactions in Veru Inc. stock. As of the latest transaction made, Morgan Stanley holds 2,731,799 shares of VERU stock, worth $2.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,731,799
Previous 2,730,119 0.06%
Holding current value
$2.6 Million
Previous $1.97 Million 2.7%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$0.37 - $0.72 $621 - $1,209
1,680 Added 0.06%
2,731,799 $1.91 Million
Q4 2023

Feb 13, 2024

SELL
$0.67 - $1.17 $723,145 - $1.26 Million
-1,079,321 Reduced 28.33%
2,730,119 $1.97 Million
Q3 2023

Nov 15, 2023

SELL
$0.72 - $1.33 $981,223 - $1.81 Million
-1,362,810 Reduced 26.35%
3,809,440 $2.74 Million
Q2 2023

Aug 14, 2023

SELL
$0.98 - $1.49 $1.92 Million - $2.93 Million
-1,964,262 Reduced 27.52%
5,172,250 $6.15 Million
Q1 2023

May 15, 2023

SELL
$1.16 - $6.41 $182,444 - $1.01 Million
-157,280 Reduced 2.16%
7,136,512 $8.28 Million
Q4 2022

Feb 14, 2023

BUY
$4.78 - $15.01 $4.54 Million - $14.3 Million
949,478 Added 14.97%
7,293,792 $38.5 Million
Q3 2022

Nov 14, 2022

BUY
$10.22 - $23.7 $54.6 Million - $127 Million
5,340,137 Added 531.79%
6,344,314 $73.1 Million
Q2 2022

Oct 27, 2022

BUY
$4.35 - $15.85 $3.56 Million - $13 Million
818,261 Added 440.12%
1,004,177 $11.3 Million
Q2 2022

Aug 15, 2022

BUY
$4.35 - $15.85 $3.56 Million - $13 Million
818,261 Added 440.12%
1,004,177 $11.3 Million
Q1 2022

Oct 27, 2022

SELL
$4.55 - $6.41 $3.72 Million - $5.25 Million
-818,261 Reduced 81.49%
185,916 $898,000
Q1 2022

May 13, 2022

SELL
$4.55 - $6.41 $575,834 - $811,230
-126,557 Reduced 40.5%
185,916 $898,000
Q4 2021

Feb 14, 2022

SELL
$5.89 - $9.73 $195,324 - $322,666
-33,162 Reduced 9.59%
312,473 $1.84 Million
Q3 2021

Nov 15, 2021

BUY
$6.78 - $9.89 $2.34 Million - $3.42 Million
345,635 New
345,635 $2.95 Million

Others Institutions Holding VERU

About VERU INC.


  • Ticker VERU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,146,704
  • Market Cap $76.1M
  • Description
  • Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....
More about VERU
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.